Shana Schroeder, DO
Dermatology · Delray Beach, FLNPI 1790056711
Payments from drug & device makers
Across 63 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$192
- Johnson & Johnson$185
- Novartis$143
- Galderma Laboratories, L.p.$126
- Sanofi$125
- AbbVie$125
- plus $517 from 14 others
What the payments were for
- Food & beverage$1,33394%
- Education$806%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $192 |
| Johnson & Johnson | 7 | $185 |
| Novartis | 7 | $143 |
| Galderma Laboratories, L.p. | 6 | $126 |
| Sanofi | 4 | $125 |
| AbbVie | 5 | $125 |
| Boehringer Ingelheim | 3 | $80 |
| DUSA Pharmaceuticals, Inc. | 4 | $70 |
| Mayne Pharma Commercial LLC | 2 | $52 |
| Sun Pharmaceutical Industries Inc. | 2 | $44 |
| Amgen | 2 | $41 |
| Almirall LLC | 2 | $40 |
| Biofrontera Inc. | 2 | $38 |
| UCB, Inc. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $19 |
| LEO Pharma Inc. | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$1,413 in reported general payments places this provider in the 35th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 25 | $292,902 |
| Dupixent PenDupilumab | 22 | $88,334 |
| Acitretin | 16 | $4,991 |
| Fluorouracil | 64 | $4,270 |
| Clobetasol Propionate | 121 | $3,384 |
| Ketoconazole | 124 | $2,155 |
| Imiquimod | 48 | $1,453 |
| Mupirocin | 174 | $1,149 |
| Clindamycin Phosphate | 23 | $1,085 |
| Metronidazole | 30 | $933 |
| Ciclopirox | 22 | $898 |
| Doxycycline Hyclate | 49 | $883 |
| Triamcinolone Acetonide | 77 | $727 |
| Gentamicin Sulfate | 14 | $458 |
| MethotrexateMethotrexate Sodium | 46 | $456 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Delray Beach
- Brian FeinsteinDelray Beach$3.6M
- John StrasswimmerDelray Beach$1.4M
- Andrea ColtonDelray Beach$797K
- Brent SchillingerDelray Beach$606K
- Barry KuttnerDelray Beach$597K
- Michael SherlingLake Worth$78.9M
- Seth FormanTampa$28.2M
- Thomas TaylorTampa$13.6M
- Frank DonHallandale Beach$7.5M
- Francisco FloresMiramar$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.